- No file added yet -

Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

media

posted on 2021-04-22, 14:06 authored by Adis journals on behalf of, Patricia Pozo-Rosich, Karen H. Samaan, Todd J. Schwedt, Robert A. Nicholson, Mallikarjuna Rettiganti, Eric M. Pearlman

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).